baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out AMGN/ DE000UH3AUP6 /

10/05/2024 21:55:01	Chg.-0.030	Bid-	Ask-	Underlying	Strike price	Expiration date	Option type
1.080EUR	-2.70%	- Bid Size: -	- Ask Size: -	Amgen Inc	194.0356 USD	31/12/2078	Call

GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...

GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

TeleTrader 08/05 US closes flat to higher with more earnings on the horizon

GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

TeleTrader 03/05 US closes higher after softer-than-expected jobs print

TeleTrader 03/05 Wall Street surges on open as jobs report sparks rate cut hopes

TeleTrader 03/05 Amgen soars 14% on positive weight-loss drug data

TeleTrader 02/05 Amgen Q1 revenue jumps 22% to $7.4 billion

TeleTrader 02/05 US surges at close as traders weigh Fed remarks

TeleTrader 02/05 US opens higher, Dow jumps 240 points

GlobeNewswire 02/05 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...

TeleTrader 02/05 US higher premarket after Fed's decision

GlobeNewswire 01/05 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...

GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

GlobeNewswire 30/04 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...

GlobeNewswire 24/04 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...

TeleTrader 24/04 Wall Street opens mostly higher amid earnings jitters

GlobeNewswire 23/04 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

GlobeNewswire 16/04 Turnstone Biologics Appoints William Waddill to its Board of Directors

GlobeNewswire 15/04 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 15/04 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

GlobeNewswire 15/04 Shah Capital nominates two highly qualified independent director candidates for Novavax

UBS Knock-Out AMGN/ DE000UH3AUP6 /

If you wish to receive reply to your feedback, please provide your email address.